Jagadeesh, D., Taszner, M., Chong, G., Novelli, S., Cho, S., Villasboas, J. C., Merli, M., Ubieto, A. J., Tessoulin, B., Poon, M., Tucker, D., Walewski, J. A., Yi, S., Cai, J., Brouwer-Visser, J., Chaudhry, A., Mohamed, H., Ambati, S. R., Kim, T. M. (2025). Long-term follow-up of the phase 2 ELM-2 study: Odronextamab for patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7049